(2024) Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021. The Lancet. pp. 2204-2256. ISSN 01406736 (ISSN)

(2024) Effects of adjuvants (granulocyte-macrophage colony-stimulating factor, levamisole, adjuvant system 04, adjuvant system 02B) on enhancing immune response to hepatitis B vaccine: a systematic review and meta-analysis. Reviews and Research in Medical Microbiology. pp. 78-87. ISSN 2770-3150